News Release: July 18, 2025
Mannitol Price Trend in Past Five Years and Factors Impacting Price Movements (2019–2024)
Mannitol, a sugar alcohol widely used in the pharmaceutical, food, and industrial sectors, has witnessed a fluctuating price trend over the past five years. Its market behavior has been heavily influenced by raw material availability, global demand, production disruptions, and supply chain bottlenecks.
In 2019, the average price of mannitol was around $1,200/MT. The market was relatively stable during this period due to consistent production in key manufacturing hubs like China, India, and the United States. However, the onset of the COVID-19 pandemic in 2020 disrupted this trend significantly. During the early months of 2020, prices spiked up to $1,550/MT due to labor shortages, logistics challenges, and temporary plant shutdowns across Asia and Europe.
In the second half of 2020, as global production resumed, the price declined slightly to $1,400/MT. The pharmaceutical industry’s increasing dependence on mannitol as an excipient and its role in intravenous solutions added consistent pressure on demand, helping stabilize prices.
Moving into 2021, the price of mannitol experienced an upward shift again, climbing to an average of $1,620/MT. This was largely due to continued demand from the food processing industry, which was still grappling with post-pandemic adjustments and bulk-buying behavior among suppliers. Additionally, tighter environmental regulations in China impacted the availability of starch-based raw materials used in mannitol production, pushing prices up further.
By mid-2022, market dynamics changed due to increased mannitol production capacity in India and Southeast Asia. This led to a brief dip in prices, reaching about $1,480/MT. However, that drop was short-lived, as global inflation and energy costs surged in the latter half of the year, causing production costs to rise. By the end of 2022, mannitol prices once again climbed to $1,700/MT.
The year 2023 marked a period of relative stability, with average global mannitol prices hovering around $1,720/MT. Technological improvements and expansions in fermentation-based production methods helped balance costs. Yet, high demand in pharmaceutical formulations, particularly in emerging economies, continued to limit any potential price declines.
Entering 2024, mannitol price news highlighted another round of price increases due to geopolitical tensions in Eastern Europe and the Middle East. These conflicts indirectly impacted energy prices and trade routes, pushing mannitol prices to an average of $1,780/MT by year-end. Additionally, the rise in demand for sugar substitutes and polyols in health-conscious markets further supported higher pricing.
In summary, over the last five years, the mannitol price trend has moved from $1,200/MT in 2019 to approximately $1,780/MT by the end of 2024. While production capabilities have improved and new facilities have come online, market volatility, demand shifts, and supply chain pressures have kept prices dynamic. The outlook for 2025 suggests further activity in this space, with a continued focus on cost control and efficiency in mannitol production.
Mannitol price trend and production News
Mannitol Price Trend Quarterly Update in $/MT (2025 Estimate)
Based on prevailing market dynamics and projected demand-supply scenarios, the estimated quarterly mannitol prices for 2025 are:
- Q1 2025: $1,790/MT – Stable demand from pharma and food sectors, minor seasonal production slowdown.
- Q2 2025: $1,810/MT – Increased demand from export markets, rising transportation costs.
- Q3 2025: $1,840/MT – Peak seasonal demand for processed foods and IV formulations.
- Q4 2025: $1,800/MT – Slight correction due to higher inventory levels and supply normalization.
The mannitol price news landscape indicates that 2025 may see tighter pricing margins but no significant collapses, owing to globally increasing sales volumes and diversification in production geographies.
Global Mannitol Import-Export Business Overview
The international trade of mannitol has become more interconnected in recent years, driven by increased consumption across pharmaceutical, food, and industrial applications. Mannitol production has seen notable geographic shifts, particularly with developing countries stepping up their role as key suppliers.
Historically, China has dominated global mannitol production, accounting for over 40% of global output. Its robust manufacturing infrastructure and ready access to corn starch and cassava—the primary raw materials—have made it a leading exporter. However, environmental policies and increased domestic demand have constrained its export capacities in recent years.
India has emerged as a strong alternative in the global mannitol export scene. With its pharmaceutical and nutraceutical sectors expanding rapidly, India has not only increased its own mannitol production but also amplified its export reach into Southeast Asia, Africa, and Europe. By the end of 2024, India accounted for approximately 18% of global mannitol exports.
The United States, while a net importer of mannitol, remains an important player due to its large pharmaceutical industry. Its imports have steadily grown year over year, with 2024 seeing over 30,000 MT of mannitol imported, primarily from China and India. The demand is largely driven by injectable formulations and tablet binders.
Europe remains a complex market for mannitol trade. Western European countries like Germany, France, and the UK are significant importers, particularly of pharmaceutical-grade mannitol. Their stringent quality norms and regulatory requirements make them high-value markets. Eastern Europe, on the other hand, has become a hub for mid-scale manufacturing facilities that cater to both local and export demand.
In 2024, global mannitol import-export volumes crossed 180,000 MT. Exporters favored markets with clear regulatory pathways and strong demand forecasts. Southeast Asian nations like Vietnam, Thailand, and Malaysia saw a rise in mannitol imports, fueled by a booming processed food sector and increasing investments in healthcare infrastructure.
Trade challenges also surfaced during this time. Supply chain disruptions, container shortages, and increased freight costs particularly impacted shipments from Asia to Europe and North America. In some instances, mannitol sales volume dipped not due to reduced demand, but logistical constraints.
On the demand side, Africa has become a rising player, importing more mannitol for use in intravenous medical formulations and industrial applications. Countries like South Africa, Kenya, and Nigeria have invested in public healthcare expansion, thereby increasing procurement contracts involving mannitol.
South America presents a mixed picture. Brazil leads in mannitol consumption, both in food and pharma, but imports most of its supply. Argentina and Chile also show steady demand, although currency volatility often influences trade volumes and pricing.
Recent mannitol news highlights trade diversification. With geopolitical uncertainties in some traditional supply corridors, buyers are now actively sourcing from multiple regions to ensure supply stability. This shift is expected to continue in 2025, improving resilience in the mannitol market.
The mannitol price news from early 2025 suggests that global buyers are also beginning to sign long-term contracts to hedge against sudden price hikes. This strategy, coupled with forward inventory stocking, is altering the pace and seasonality of the global import-export flows.
Mannitol sales volume is expected to continue its upward trajectory in 2025. New manufacturing units in Indonesia and Turkey are expected to go operational by mid-2025, which could add over 20,000 MT annually to global supply. These developments may ease the pricing pressure and bring more competitive offerings into the market.
Furthermore, digitalization in logistics and real-time demand forecasting are being adopted by major traders, enhancing the efficiency of mannitol export management. This transformation is likely to impact not only pricing but also responsiveness to short-term demand surges.
The global mannitol business landscape in 2025 remains competitive and dynamic. Production hubs are becoming more geographically diversified, and trade flows are increasingly influenced by both macroeconomic factors and sector-specific demand. As long as pharmaceutical and food-grade applications remain robust, mannitol production and trade will continue to expand.
For more detailed data on Mannitol sales volume, production forecasts, and trade analytics, request a sample at:
Mannitol Production Trends by Geography
Mannitol production is geographically concentrated in a few key regions, with emerging economies beginning to challenge long-standing production centers. The global spread of mannitol production has been influenced by factors such as raw material availability, cost of production, infrastructure capabilities, and regional demand from end-user industries like pharmaceuticals and food processing. As of 2025, Asia-Pacific, Europe, and North America are the major contributors to mannitol production, with noticeable growth in Latin America and parts of the Middle East.
Asia-Pacific
Asia-Pacific remains the dominant force in mannitol production. China is the single largest producer in the region and globally. The country has extensive access to corn and cassava, the primary raw materials used in mannitol manufacturing through catalytic hydrogenation and fermentation processes. China’s established manufacturing infrastructure, low labor costs, and robust domestic demand ensure that it remains the epicenter of global mannitol production.
India is emerging as another important hub for mannitol manufacturing. The rapid expansion of its pharmaceutical and food processing industries has driven local production. Additionally, government initiatives to support industrial growth, attract foreign investment, and improve manufacturing capabilities are reinforcing India’s position as a growing mannitol producer. Indian companies are also focusing on meeting global standards to improve their export potential, especially to Europe and North America.
South Korea and Japan also have niche mannitol production capabilities, mainly focused on pharmaceutical-grade applications. These countries prioritize quality over quantity and cater to high-value markets with stringent regulatory requirements.
Southeast Asia, particularly Thailand and Indonesia, is seeing a rise in investment for polyol and sugar alcohol production. These countries offer low-cost production environments and strategic geographic locations that support export-based growth strategies.
Europe
Europe holds a strong position in mannitol production, especially in Western and Central Europe. Countries like France, Germany, and the Netherlands are key contributors. European manufacturers often emphasize sustainable and high-purity production methods, targeting premium pharmaceutical and food markets.
Regulatory frameworks in the EU require adherence to strict quality control measures. This emphasis on high standards allows European mannitol producers to command premium prices in international markets. However, higher energy and labor costs in the region restrict the scale of production compared to Asia.
Eastern European countries are gradually building production capacities as part of broader chemical and pharmaceutical manufacturing strategies. These nations benefit from proximity to Western markets while offering more competitive production costs.
North America
In North America, the United States is the leading producer of mannitol. Although the region imports a significant portion of its mannitol needs, domestic production is focused on high-purity and specialty-grade variants. The U.S. pharmaceutical industry relies heavily on mannitol, especially for injectable drugs and tablet formulations.
Canada has limited production capabilities but is involved in R&D and pilot-scale manufacturing. The region’s reliance on imported raw materials and high operational costs limit large-scale mannitol manufacturing.
Latin America
Latin America is a growing region in the mannitol production landscape. Brazil leads the region due to its strong agricultural base and improving chemical production infrastructure. The country has begun to invest in bio-based production methods, utilizing sugarcane and corn feedstocks.
Argentina and Colombia are exploring partnerships and technology transfers to build local mannitol manufacturing capabilities. While still nascent, these efforts are part of regional initiatives to reduce import dependency and boost local industrial production.
Middle East and Africa
The Middle East is seeing limited but growing activity in mannitol production. Countries like the United Arab Emirates are investing in specialty chemicals, including sugar alcohols, as part of diversification strategies away from oil dependence. However, high raw material import costs and water scarcity issues pose challenges to scale.
Africa is still in the early stages of establishing mannitol production capabilities. South Africa is the most active player, with a few local companies exploring fermentation-based production methods. Most of the continent remains reliant on imports to meet pharmaceutical and food-grade mannitol demand.
In summary, mannitol production trends in 2025 reflect a global shift towards decentralization and diversification. While China and India continue to dominate in terms of volume, new production hubs are emerging in Southeast Asia, Latin America, and Eastern Europe. These developments are expected to stabilize global supply chains, reduce price volatility, and improve access to mannitol in both established and developing markets.
Mannitol Market Segmentation
Market Segmentation of Mannitol
- By Product Form:
- Powder
- Granular
- Liquid
- By Application:
- Pharmaceuticals
- Food and Beverages
- Personal Care and Cosmetics
- Industrial Applications
- By End Use:
- Hospitals and Clinics
- Food Manufacturers
- Industrial Chemical Companies
- Retail and Consumer
- By Grade:
- Food Grade
- Pharmaceutical Grade
- Industrial Grade
- By Distribution Channel:
- Direct/B2B Sales
- Distributors
- Online Retail
Detailed Explanation of Leading Segments
The mannitol market is characterized by its wide range of applications across several industries. While it is used in multiple forms and grades, the pharmaceutical and food sectors remain the leading segments both in terms of volume and value.
Pharmaceutical Application Segment
The pharmaceutical segment is the largest consumer of mannitol. It is used as an excipient in tablets, especially for patients with diabetes due to its non-glycemic nature. Additionally, mannitol is commonly employed in injectable solutions to reduce intracranial pressure and treat kidney disorders. This segment’s demand is primarily driven by the rising prevalence of chronic diseases and increasing production of generic and branded medications globally.
Countries like the United States, Germany, and India are major hubs for pharmaceutical manufacturing, leading to consistent demand for pharmaceutical-grade mannitol. High standards of purity and stringent regulations mean that manufacturers in this segment invest heavily in advanced purification technologies.
Food and Beverage Application Segment
This segment accounts for the second-largest market share. Mannitol is used as a low-calorie sweetener in chewing gums, baked goods, candies, and sugar-free confectionery. It provides the desired mouthfeel and sweetness without raising blood glucose levels, making it ideal for diabetic-friendly products.
Growing health awareness, increasing demand for sugar alternatives, and government support for low-sugar diets are all contributing to the growth of this segment. Europe and North America are mature markets, while Asia-Pacific, especially China and Japan, are rapidly increasing their consumption of mannitol-based food products.
By Product Form: Powder and Granular
Powder and granular forms of mannitol dominate the market. These forms are easier to handle, store, and mix in formulations, especially in pharmaceuticals and food processing. The powdered form is particularly preferred in intravenous solutions and tablet formulations. Granular mannitol finds higher use in food applications due to its texture and stability.
The liquid form of mannitol is less common but is gaining traction in industrial and cosmetic applications, where solubility and rapid absorption are essential.
By Grade: Pharmaceutical Grade Leads
Pharmaceutical-grade mannitol has the highest market value due to its purity and compliance with pharmacopeial standards. It is mostly sold via long-term contracts to major drug manufacturers, ensuring demand stability and pricing power. The growth in the global pharmaceutical sector continues to support this segment’s expansion.
Food-grade mannitol follows, driven by rising demand for clean-label, sugar-free, and low-calorie food products. The demand for industrial-grade mannitol is relatively smaller and focused on specific chemical and technical applications, including use as a chemical intermediate.
By Distribution Channel: B2B Dominance
Direct business-to-business (B2B) sales dominate the distribution landscape. Manufacturers prefer selling directly to large pharmaceutical and food companies to maintain volume commitments and product traceability. Distributors are active in regions with fragmented demand, like parts of Africa and Latin America.
Online sales are minimal but growing. Smaller food and cosmetic manufacturers are increasingly sourcing mannitol through e-commerce platforms, especially in emerging markets where traditional supply chains are less developed.
By End Use: Hospitals and Food Manufacturers Lead
Hospitals and clinics represent a key end-user group, especially in the intravenous formulation space. With increasing public healthcare investments globally, this segment is expected to grow steadily.
Food manufacturers use mannitol in developing innovative, health-oriented products. With ongoing product launches in the low-calorie and diabetic food category, this segment continues to push the boundaries of mannitol consumption.
In conclusion, mannitol market segmentation reveals that pharmaceuticals and food applications are the main drivers of global demand. Powder and granular forms, especially of pharmaceutical and food grade, remain the preferred choice across industries. As global health consciousness rises and the pharmaceutical sector continues its growth, mannitol is set to play an increasingly important role in various commercial and clinical applications.